Year |
Citation |
Score |
2023 |
Mueller C, Fang YD, Jones C, McConathy JE, Raman F, Lapi SE, Younger JW. Evidence of neuroinflammation in fibromyalgia syndrome: a [18F]DPA-714 positron emission tomography study. Pain. PMID 37326674 DOI: 10.1097/j.pain.0000000000002927 |
0.733 |
|
2022 |
Fang YD, McConathy JE, Yacoubian TA, Zhang Y, Kennedy RE, Standaert DG. Image Quantification for TSPO PET with a Novel Image-Derived Input Function Method. Diagnostics (Basel, Switzerland). 12. PMID 35626315 DOI: 10.3390/diagnostics12051161 |
0.312 |
|
2021 |
Galgano SJ, Calderone CE, Xie C, Smith EN, Porter KK, McConathy JE. Applications of PET/MRI in Abdominopelvic Oncology. Radiographics : a Review Publication of the Radiological Society of North America, Inc. 41: 1750-1765. PMID 34597228 DOI: 10.1148/rg.2021210035 |
0.355 |
|
2021 |
Moradi F, Iagaru A, McConathy J. Clinical Applications of PET/MR Imaging. Radiologic Clinics of North America. 59: 853-874. PMID 34392923 DOI: 10.1016/j.rcl.2021.05.013 |
0.378 |
|
2021 |
Catana C, Laforest R, An H, Boada F, Cao T, Faul D, Jakoby B, Jansen FP, Kemp BJ, Kinahan PE, Larson PEZ, Levine MA, Maniawski P, Mawlawi O, McConathy J, et al. A Path to Qualification of PET/MR Scanners for Multicenter Brain Imaging Studies: Evaluation of MR-based Attenuation Correction Methods Using a Patient Phantom. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 34301784 DOI: 10.2967/jnumed.120.261881 |
0.363 |
|
2021 |
Raman F, Fang YD, Grandhi S, Murchison CF, Kennedy RE, Morris JC, Massoumzadeh P, Benzinger T, Roberson ED, McConathy J. Dynamic Amyloid PET: Relationships to Flortaucipir Tau PET Measures. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 34049986 DOI: 10.2967/jnumed.120.254490 |
0.764 |
|
2020 |
Murchison CF, Kennedy RE, McConathy JE, Roberson ED. Racial Differences in Alzheimer's Disease Specialist Encounters are Associated with Usage of Molecular Imaging and Dementia Medications: An Enterprise-Wide Analysis Using i2b2. Journal of Alzheimer's Disease : Jad. PMID 33337364 DOI: 10.3233/JAD-200796 |
0.464 |
|
2020 |
Ponisio MR, McConathy JE, Dahiya SM, Miller-Thomas MM, Rich KM, Salter A, Wang Q, LaMontagne PJ, Guzmán Pérez-Carrillo GJ, Benzinger TLS. Dynamic F-FDOPA-PET/MRI for the preoperative evaluation of gliomas: correlation with stereotactic histopathology. Neuro-Oncology Practice. 7: 656-667. PMID 33312679 DOI: 10.1093/nop/npaa044 |
0.436 |
|
2020 |
Jansen FP, Deller TW, Fries MD, Khalighi MM, White SL, Radford LL, McConathy JE, Lapi SE. Real-Time Gain Control of PET Detectors and Evaluation with Challenging Radionuclides. Ieee Transactions On Medical Imaging. PMID 32894710 DOI: 10.1109/Tmi.2020.3022321 |
0.339 |
|
2020 |
Hoyle JM, Lenzie A, Galgano SJ, McConathy JE, Rais-Bahrami S, Nix JW, McDonald AM. Synchronous Malignancies Identified by F-fluciclovine Positron Emission Tomography for Prostate Cancer: Case Series and Mini-Review. Clinical Genitourinary Cancer. PMID 32771333 DOI: 10.1016/j.clgc.2020.07.009 |
0.364 |
|
2020 |
Aryal SR, Bajaj NS, Bansal NC, Hage FG, McConathy JE, Bhambhvani P. FDG-PET/CT diagnosis of aortitis and pseudoaneurysms. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. PMID 32180135 DOI: 10.1007/s12350-020-02085-5 |
0.391 |
|
2020 |
Galgano SJ, Valentin R, McConathy J. Role of PET imaging for biochemical recurrence following primary treatment for prostate cancer. Translational Andrology and Urology. 7: S462-S476. PMID 30363475 DOI: 10.21037/tau.2018.06.09 |
0.304 |
|
2020 |
Galgano SJ, McDonald AM, Rais-Bahrami S, Choudhary G, Bhambhvani P, McConathy J. [18F]Fluciclovine-PET/MRI use in monitoring response to androgen deprivation therapy in men with prostate cancer following initial staging. Journal of Clinical Oncology. 38: 216-216. DOI: 10.1200/jco.2020.38.6_suppl.216 |
0.372 |
|
2019 |
Wang Q, Pérez-Carrillo GJG, Ponisio MR, LaMontagne P, Dahiya S, Marcus DS, Milchenko M, Shimony J, Liu J, Chen G, Salter A, Massoumzadeh P, Miller-Thomas MM, Rich KM, McConathy J, et al. Heterogeneity Diffusion Imaging of gliomas: Initial experience and validation. Plos One. 14: e0225093. PMID 31725772 DOI: 10.1371/journal.pone.0225093 |
0.315 |
|
2019 |
McDonald AM, Galgano SJ, McConathy JE, Yang ES, Dobelbower MC, Jacob R, Rais-Bahrami S, Nix JW, Popple RA, Fiveash JB. Feasibility of Dose Escalating [F]fluciclovine Positron Emission Tomography Positive Pelvic Lymph Nodes During Moderately Hypofractionated Radiation Therapy for High-Risk Prostate Cancer. Advances in Radiation Oncology. 4: 649-658. PMID 31673658 DOI: 10.1016/J.Adro.2019.05.008 |
0.377 |
|
2019 |
Kasten BB, Udayakumar N, Leavenworth JW, Wu AM, Lapi SE, McConathy JE, Sorace AG, Bag AK, Markert JM, Warram JM. Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-Oncology. Theranostics. 9: 5085-5104. PMID 31410203 DOI: 10.7150/Thno.34415 |
0.341 |
|
2019 |
Raman F, Grandhi S, Murchison CF, Kennedy RE, Landau S, Roberson ED, McConathy J. Biomarker Localization, Analysis, Visualization, Extraction, and Registration (BLAzER) Methodology for Research and Clinical Brain PET Applications. Journal of Alzheimer's Disease : Jad. PMID 31322571 DOI: 10.3233/JAD-190329 |
0.762 |
|
2019 |
Triche BL, Nelson JT, McGill NS, Porter KK, Sanyal R, Tessler FN, McConathy JE, Gauntt DM, Yester MV, Singh SP. Recognizing and Minimizing Artifacts at CT, MRI, US, and Molecular Imaging. Radiographics : a Review Publication of the Radiological Society of North America, Inc. 39: 1017-1018. PMID 31283460 DOI: 10.1148/rg.2019180022 |
0.348 |
|
2019 |
Murchison CF, Kennedy RE, McConathy J, Roberson ED. P3-497: VARIATIONS IN REFERRALS, ASSESSMENTS AND TREATMENT OF ALZHEIMER'S DISEASE FOR AFRICAN AMERICANS IN THE DEEP SOUTH Alzheimer's & Dementia. 15: P1159-P1159. DOI: 10.1016/j.jalz.2019.06.3532 |
0.477 |
|
2018 |
Law I, Albert NL, Arbizu J, Boellaard R, Drzezga A, Galldiks N, la Fougère C, Langen KJ, Lopci E, Lowe V, McConathy J, Quick HH, Sattler B, Schuster DM, Tonn JC, et al. Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [F]FDG: version 1.0. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30519867 DOI: 10.1007/s00259-018-4207-9 |
0.485 |
|
2018 |
Galgano SJ, Calderone CE, McDonald AM, Nix JW, deShazo M, Yang ES, McConathy JE, Rais-Bahrami S. Case Studies in Clinical Practice Management: Patient Demographics and Referral Patterns for [F-18]Fluciclovine-PET Imaging at a Tertiary Academic Medical Center. Journal of the American College of Radiology : Jacr. PMID 30447932 DOI: 10.1016/J.Jacr.2018.09.026 |
0.397 |
|
2018 |
Choudhary G, Langen KJ, Galldiks N, McConathy J. Investigational PET tracers for high-grade gliomas. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar), [and] Section of the Society of.... 62: 281-294. PMID 29869489 DOI: 10.23736/S1824-4785.18.03105-9 |
0.463 |
|
2018 |
Prudner BC, Sun F, Kremer JC, Xu J, Huang C, Sai KKS, Morgan Z, Leeds H, McConathy J, Van Tine BA. Amino Acid Uptake Measured by [F]AFETP Increases in Response to Arginine Starvation in ASS1-Deficient Sarcomas. Theranostics. 8: 2107-2116. PMID 29721066 DOI: 10.7150/thno.22083 |
0.449 |
|
2018 |
Hathi D, DeLassus E, Achilefu S, McConathy J, Shokeen M. Imaging melphalan therapy response in preclinical extramedullary myeloma with F-FDOPA and F-FDG PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29700126 DOI: 10.2967/Jnumed.118.208744 |
0.472 |
|
2018 |
Gauvain K, Ponisio MR, Barone A, Grimaldi M, Parent E, Leeds H, Goyal M, Rubin J, McConathy J. F-FDOPA PET/MRI for monitoring early response to bevacizumab in children with recurrent brain tumors. Neuro-Oncology Practice. 5: 28-36. PMID 29692922 DOI: 10.1093/nop/npx008 |
0.42 |
|
2018 |
Galgano S, Viets Z, Fowler K, Gore L, Thomas JV, McNamara M, McConathy J. Practical Considerations for Clinical PET/MR Imaging. Pet Clinics. 13: 97-112. PMID 29157390 DOI: 10.1016/j.cpet.2017.09.002 |
0.45 |
|
2018 |
Galgano SJ, Marshall RV, Middlebrooks EH, McConathy JE, Bhambhvani P. PET/MR Imaging in Head and Neck Cancer: Current Applications and Future Directions. Magnetic Resonance Imaging Clinics of North America. 26: 167-178. PMID 29128003 DOI: 10.1016/j.mric.2017.08.010 |
0.441 |
|
2017 |
Zarzour JG, Galgano S, McConathy J, Thomas JV, Rais-Bahrami S. Lymph node imaging in initial staging of prostate cancer: An overview and update. World Journal of Radiology. 9: 389-399. PMID 29104741 DOI: 10.4329/wjr.v9.i10.389 |
0.351 |
|
2017 |
Subramaniam RM, Jadvar H, Colletti PM, Guimaraes A, Gullapali R, Iagaru AH, McConathy J, Meltzer CC, Nadel H, Noto RB, Packard AB, Rohren E, Oates ME. American College of Radiology and Society of Nuclear Medicine and Molecular Imaging Joint Credentialing Statement for PET/MR Imaging: Body. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28473601 DOI: 10.2967/jnumed.117.193524 |
0.385 |
|
2017 |
Galgano S, Viets Z, Fowler K, Gore L, Thomas JV, McNamara M, McConathy J. Practical Considerations for Clinical PET/MR Imaging. Magnetic Resonance Imaging Clinics of North America. 25: 281-296. PMID 28390529 DOI: 10.1016/j.mric.2016.12.006 |
0.45 |
|
2016 |
Fraum TJ, Fowler KJ, McConathy J, Dehdashti F. Indeterminate Findings on Oncologic PET/CT: What Difference Does PET/MRI Make? Nuclear Medicine and Molecular Imaging. 50: 292-299. PMID 27994684 DOI: 10.1007/s13139-016-0405-1 |
0.45 |
|
2016 |
Fraum TJ, Fowler KJ, McConathy J. Conspicuity of FDG-Avid Osseous Lesions on PET/MRI Versus PET/CT: a Quantitative and Visual Analysis Nuclear Medicine and Molecular Imaging. 50: 228-239. PMID 27540427 DOI: 10.1007/S13139-016-0403-3 |
0.401 |
|
2016 |
Minoshima S, Drzezga AE, Barthel H, Bohnen N, Djekidel M, Lewis DH, Mathis CA, McConathy J, Nordberg A, Sabri O, Seibyl JP, Stokes MK, Van Laere K. SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 57: 1316-22. PMID 27481605 DOI: 10.2967/Jnumed.116.174615 |
0.433 |
|
2016 |
Wang L, Benzinger TL, Su Y, Christensen J, Friedrichsen K, Aldea P, McConathy J, Cairns NJ, Fagan AM, Morris JC, Ances BM. Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy. Jama Neurology. PMID 27454922 DOI: 10.1001/Jamaneurol.2016.2078 |
0.318 |
|
2016 |
Miller-Thomas MM, Sipe AL, Benzinger TL, McConathy J, Connolly S, Schwetye KE. Multimodality Review of Amyloid-related Diseases of the Central Nervous System. Radiographics : a Review Publication of the Radiological Society of North America, Inc. 36: 1147-63. PMID 27399239 DOI: 10.1148/Rg.2016150172 |
0.329 |
|
2016 |
Gordon BA, Friedrichsen K, Brier M, Blazey T, Su Y, Christensen J, Aldea P, McConathy J, Holtzman DM, Cairns NJ, Morris JC, Fagan AM, Ances BM, Benzinger TL. The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging. Brain : a Journal of Neurology. PMID 27286736 DOI: 10.1093/Brain/Aww139 |
0.335 |
|
2016 |
McConathy J. 18F-Fluciclovine (FACBC) and Its Potential Use for Breast Cancer Imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 57: 1329-30. PMID 27199361 DOI: 10.2967/jnumed.116.175489 |
0.331 |
|
2016 |
Sotoudeh H, Sharma A, Fowler KJ, McConathy J, Dehdashti F. Clinical application of PET/MRI in oncology. Journal of Magnetic Resonance Imaging : Jmri. PMID 27007987 DOI: 10.1002/jmri.25161 |
0.45 |
|
2016 |
Ponisio MR, McConathy J, Laforest R, Khanna G. Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma. Pediatric Radiology. 46: 1258-68. PMID 27003132 DOI: 10.1007/s00247-016-3601-3 |
0.355 |
|
2016 |
Ponisio MR, McConathy J, Laforest R, Khanna G. Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma. Pediatric Radiology. 46: 1258-68. PMID 27003132 DOI: 10.1007/s00247-016-3601-3 |
0.355 |
|
2016 |
Bouhlel A, Alyami W, Li A, Yuan L, Rich KM, McConathy J. Effect of α-methyl versus α-hydrogen substitution on brain availability and tumor imaging properties of heptanoic [F-18]fluoroalkyl amino acids for positron emission tomography (PET). Journal of Medicinal Chemistry. PMID 26967318 DOI: 10.1021/acs.jmedchem.6b00189 |
0.458 |
|
2016 |
Su Y, Rubin B, McConathy J, Laforest R, Qi J, Sharma A, Priatna A, Benzinger T. Impact of MR based attenuation correction on neurological PET studies. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26823562 DOI: 10.2967/jnumed.115.164822 |
0.455 |
|
2016 |
Gauvain K, Barone A, Grimaldi M, Parent E, Ponisio M, Leeds H, Goyal M, Rubin J, McConathy J. RA-03FDOPA-PET/MRI FOR RECURRENT PEDIATRIC BRAIN TUMORS Neuro-Oncology. 18: iii165.2-iii165. DOI: 10.1093/neuonc/now083.02 |
0.373 |
|
2016 |
Benzinger TLS, Gordon BA, Friedrichsen KA, Su Y, Christensen J, Hornbeck RC, Mishra S, Aldea P, Cash L, Ances B, McConathy J, Koeppe RA, McDade E, Cairns NJ, Morris JC, et al. Tau Pet Imaging With Av-1451 In Autosomal Dominant Alzheimer'S Disease: Update From The Dominantly Inherited Alzheimer Network (Dian) Alzheimers & Dementia. 12: 378. DOI: 10.1016/J.Jalz.2016.06.709 |
0.379 |
|
2016 |
Friedrichsen KA, Ghoshal N, Joseph-Mathurin N, Mishra S, Su Y, Christensen J, Aldea P, McConathy J, Gordon BA, Ances B, Cairns NJ, Morris JC, Benzinger TL. IC-P-206: Similarities and Differences in Patterns of [F18]-Av-1451 And [F18]-FDG in Frontotemporal Dementia Alzheimer's & Dementia. 12: P147-P147. DOI: 10.1016/J.Jalz.2016.06.238 |
0.359 |
|
2016 |
Friedrichsen KA, Mishra S, Gordon BA, Ghoshal N, Su Y, Joseph-Mathurin N, Christensen J, Aldea P, McConathy J, Ances B, Cairns NJ, Morris JC, Benzinger TL. IC-P-204: Principal Component Analysis of [18F]-Av-1451 TAU PET in Alzheimer’s Disease and Frontotemporal Dementia Alzheimer's & Dementia. 12: P145-P146. DOI: 10.1016/J.Jalz.2016.06.236 |
0.377 |
|
2016 |
Gordon BA, Friedrichsen KA, Brier MR, Blazey T, Su Y, Christensen J, McConathy J, Aldea P, Holtzman DM, Cairns NJ, Morris JC, Fagan AM, Ances B, Benzinger TL. P1-263: Relating PET and CSF Measure of TAU Pathology Alzheimer's & Dementia. 12: P513-P514. DOI: 10.1016/J.Jalz.2016.06.1012 |
0.372 |
|
2015 |
Zhou D, Chu W, Peng X, McConathy J, Mach RH, Katzenellenbogen JA. Facile purification and click labeling with 2-[(18)F]fluoroethyl azide using solid phase extraction cartridges. Tetrahedron Letters. 56: 952-954. PMID 26989269 DOI: 10.1016/J.Tetlet.2014.10.126 |
0.367 |
|
2015 |
Fraum TJ, Fowler KJ, McConathy J. PET/MRI: Emerging Clinical Applications in Oncology. Academic Radiology. 23: 220-36. PMID 26521689 DOI: 10.1016/j.acra.2015.09.008 |
0.344 |
|
2015 |
Fraum TJ, Fowler KJ, McConathy J. PET/MRI: Emerging Clinical Applications in Oncology. Academic Radiology. 23: 220-36. PMID 26521689 DOI: 10.1016/j.acra.2015.09.008 |
0.344 |
|
2015 |
Lau JM, Laforest R, Sotoudeh H, Nie X, Sharma S, McConathy J, Novak E, Priatna A, Gropler RJ, Woodard PK. Evaluation of attenuation correction in cardiac PET using PET/MR. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. PMID 26499770 DOI: 10.1007/s12350-015-0197-1 |
0.453 |
|
2015 |
Burkemper JL, Huang C, Li A, Yuan L, Rich K, McConathy J, Lapi SE. Synthesis and Biological Evaluation of (S)-amino-2-methyl-4-[(76)Br]-bromo-3-(E)-butenoic Acid (BrVAIB) for Brain Tumor Imaging. Journal of Medicinal Chemistry. PMID 26444035 DOI: 10.1021/Acs.Jmedchem.5B01035 |
0.415 |
|
2015 |
Vlassenko AG, McConathy J, Couture LE, Su Y, Massoumzadeh P, Leeds HS, Chicoine MR, Tran DD, Huang J, Dahiya S, Marcus DS, Fouke SJ, Rich KM, Raichle ME, Benzinger TL. Aerobic Glycolysis as a Marker of Tumor Aggressiveness: Preliminary Data in High Grade Human Brain Tumors. Disease Markers. 2015: 874904. PMID 26424903 DOI: 10.1155/2015/874904 |
0.408 |
|
2015 |
Bouhlel A, Zhou D, Li A, Yuan L, Rich KM, McConathy J. Synthesis, Radiolabeling, and Biological Evaluation of (R)- and (S)-2-Amino-5-[(18)F]fluoro-2-methylpentanoic Acid ((R)-, (S)-[(18)F]FAMPe) as Potential Positron Emission Tomography Tracers for Brain Tumors. Journal of Medicinal Chemistry. 58: 3817-29. PMID 25843369 DOI: 10.1021/jm502023y |
0.472 |
|
2015 |
Fraum TJ, Fowler KJ, McConathy J, Parent EE, Dehdashti F, Grigsby PW, Siegel BA. PET/MRI for the body imager: abdominal and pelvic oncologic applications. Abdominal Imaging. PMID 25805557 DOI: 10.1007/s00261-015-0390-3 |
0.34 |
|
2015 |
Jadvar H, Subramaniam RM, Berman CG, Boada F, Colletti PM, Guimaraes AR, McConathy J, Meltzer CC, Noto RB, Packard AB, Rohren EM, Oates ME. American College of Radiology and Society of Nuclear Medicine and Molecular Imaging Joint Credentialing Statement for PET/MR Imaging: Brain. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 642-5. PMID 25745088 DOI: 10.2967/Jnumed.115.155218 |
0.365 |
|
2015 |
McConathy J, Sheline YI. Imaging biomarkers associated with cognitive decline: a review. Biological Psychiatry. 77: 685-92. PMID 25442005 DOI: 10.1016/j.biopsych.2014.08.024 |
0.375 |
|
2015 |
Yu W, McConathy J, Olson JJ, Goodman MM. System a amino acid transport-targeted brain and systemic tumor PET imaging agents 2-amino-3-[(18)F]fluoro-2-methylpropanoic acid and 3-[(18)F]fluoro-2-methyl-2-(methylamino)propanoic acid. Nuclear Medicine and Biology. 42: 8-18. PMID 25263130 DOI: 10.1016/j.nucmedbio.2014.07.002 |
0.618 |
|
2015 |
Barnwell J, Raptis CA, McConathy JE, Laforest R, Siegel BA, Woodard PK, Fowler K. Beyond whole-body imaging: advanced imaging techniques of PET/MRI. Clinical Nuclear Medicine. 40: e88-95. PMID 25188648 DOI: 10.1097/RLU.0000000000000567 |
0.433 |
|
2015 |
Friedrichsen KA, Benzinger TLS, Joseph-Mathurin N, Fagan AM, Cairns NJ, Stevenson TA, Su Y, Christensen J, McConathy J, Gordon B, McFarlane S, Ances B, Morris JC. Patterns of tau binding in T807-PET imaging Alzheimers & Dementia. 11: 110. DOI: 10.1016/J.Jalz.2015.06.187 |
0.391 |
|
2014 |
Jain R, Sharma A, Uliel L, Mellnick V, McConathy J. An overview of nuclear medicine studies for urgent and emergent indications. Seminars in Roentgenology. 49: 210-24. PMID 24836495 DOI: 10.1053/j.ro.2014.02.001 |
0.332 |
|
2014 |
Ferguson A, McConathy J, Su Y, Hewing D, Laforest R. Attenuation Effects of MR Headphones During Brain PET/MR Studies. Journal of Nuclear Medicine Technology. 42: 93-100. PMID 24556458 DOI: 10.2967/jnmt.113.131995 |
0.433 |
|
2014 |
Conway CR, Chibnall JT, Cumming P, Mintun MA, Gebara MA, Perantie DC, Price JL, Cornell ME, McConathy JE, Gangwani S, Sheline YI. Antidepressant response to aripiprazole augmentation associated with enhanced FDOPA utilization in striatum: a preliminary PET study. Psychiatry Research. 221: 231-9. PMID 24468015 DOI: 10.1016/J.Pscychresns.2014.01.003 |
0.354 |
|
2014 |
Wallace AN, McConathy J, Menias CO, Bhalla S, Wippold FJ. Imaging evaluation of CSF shunts. Ajr. American Journal of Roentgenology. 202: 38-53. PMID 24370127 DOI: 10.2214/AJR.12.10270 |
0.303 |
|
2013 |
Sharma A, McConathy J. Overview of PET Tracers for Brain Tumor Imaging. Pet Clinics. 8: 129-46. PMID 27157944 DOI: 10.1016/j.cpet.2013.02.001 |
0.481 |
|
2013 |
Ikotun OF, Marquez BV, Huang C, Masuko K, Daiji M, Masuko T, McConathy J, Lapi SE. Imaging the L-type amino acid transporter-1 (LAT1) with Zr-89 immunoPET. Plos One. 8: e77476. PMID 24143237 DOI: 10.1371/Journal.Pone.0077476 |
0.419 |
|
2013 |
Huang C, McConathy J. Radiolabeled amino acids for oncologic imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1007-10. PMID 23708197 DOI: 10.2967/jnumed.112.113100 |
0.433 |
|
2013 |
Sai KK, Huang C, Yuan L, Zhou D, Piwnica-Worms D, Garbow JR, Engelbach JA, Mach RH, Rich KM, McConathy J. 18F-AFETP, 18F-FET, and 18F-FDG imaging of mouse DBT gliomas. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1120-6. PMID 23650628 DOI: 10.2967/Jnumed.112.113217 |
0.456 |
|
2013 |
Huang C, McConathy J. Fluorine-18 labeled amino acids for oncologic imaging with positron emission tomography. Current Topics in Medicinal Chemistry. 13: 871-91. PMID 23590170 DOI: 10.2174/1568026611313080002 |
0.445 |
|
2013 |
Goodman MM, McConathy J. Fluorine-containing drugs as PET diagnostics (F-18 labeled tracers). Current Topics in Medicinal Chemistry. 13: 869-70. PMID 23590165 DOI: 10.2174/1568026611313080001 |
0.593 |
|
2013 |
Huang C, Yuan L, Rich KM, McConathy J. Radiosynthesis and biological evaluation of alpha-[F-18]fluoromethyl phenylalanine for brain tumor imaging. Nuclear Medicine and Biology. 40: 498-506. PMID 23528560 DOI: 10.1016/j.nucmedbio.2012.12.013 |
0.448 |
|
2013 |
Uliel L, Mellnick VM, Menias CO, Holz AL, McConathy J. Nuclear medicine in the acute clinical setting: indications, imaging findings, and potential pitfalls. Radiographics : a Review Publication of the Radiological Society of North America, Inc. 33: 375-96. PMID 23479703 DOI: 10.1148/rg.332125098 |
0.341 |
|
2013 |
Lau JM, Sharma S, Laforest R, McConathy J, Barnwell J, Priatna A, Becker LM, Foster GJ, Gropler RJ, Woodard PK. Feasibility of MRI attenuation correction in cardiac FDG-PET Journal of Cardiovascular Magnetic Resonance. 15. DOI: 10.1186/1532-429X-15-S1-O61 |
0.45 |
|
2013 |
Rubin B, Su Y, McConathy J, Blazey T, Ponisio R, Weng J, Hornbeck R, Fagan A, Xiong C, Morris J, Benzinger T. IC-O2-01: How do we define amyloid positivity in an asymptomatic population? Comparison of CSF, quantitative PET and clinical PET examinations Alzheimer's & Dementia. 9: P6-P6. DOI: 10.1016/J.Jalz.2013.04.021 |
0.382 |
|
2013 |
Sharma A, McConathy J. Overview of PET tracers for brain tumor imaging Pet Clinics. 8: 129-146. DOI: 10.1016/j.cpet.2013.02.001 |
0.352 |
|
2012 |
McConathy J, Yu W, Jarkas N, Seo W, Schuster DM, Goodman MM. Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents. Medicinal Research Reviews. 32: 868-905. PMID 21793016 DOI: 10.1002/med.20250 |
0.575 |
|
2010 |
McConathy J, Zhou D, Shockley SE, Jones LA, Griffin EA, Lee H, Adams SJ, Mach RH. Click synthesis and biologic evaluation of (R)- and (S)-2-amino-3-[1-(2-[18F]fluoroethyl)-1H-[1,2,3]triazol-4-yl]propanoic acid for brain tumor imaging with positron emission tomography. Molecular Imaging. 9: 329-42. PMID 21084029 DOI: 10.2310/7290.2010.00025 |
0.463 |
|
2010 |
Yu W, McConathy J, Williams L, Camp VM, Malveaux EJ, Zhang Z, Olson JJ, Goodman MM. Synthesis, radiolabeling, and biological evaluation of (R)- and (S)-2-amino-3-[(18)F]fluoro-2-methylpropanoic acid (FAMP) and (R)- and (S)-3-[(18)F]fluoro-2-methyl-2-N-(methylamino)propanoic acid (NMeFAMP) as potential PET radioligands for imaging brain tumors. Journal of Medicinal Chemistry. 53: 876-86. PMID 20028004 DOI: 10.1021/jm900556s |
0.57 |
|
2008 |
McConathy J, Goodman MM. Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography. Cancer Metastasis Reviews. 27: 555-73. PMID 18648909 DOI: 10.1007/s10555-008-9154-7 |
0.567 |
|
2007 |
Yu W, McConathy J, Olson J, Camp VM, Goodman MM. Facile stereospecific synthesis and biological evaluation of (S)- and (R)-2-amino-2-methyl-4-[123I]iodo-3-(E)-butenoic acid for brain tumor imaging with single photon emission computerized tomography. Journal of Medicinal Chemistry. 50: 6718-21. PMID 18052089 DOI: 10.1021/jm070476u |
0.555 |
|
2007 |
McConathy J, Capello C, Jarkas N, Stowe ZN, Owens MJ. Preparation of antidepressants for use in preclinical research. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 10: 759-63. PMID 17201995 DOI: 10.1017/S1461145706007474 |
0.714 |
|
2006 |
Plisson C, Jarkas N, McConathy J, Voll RJ, Votaw J, Williams L, Howell LL, Kilts CD, Goodman MM. Evaluation of carbon-11-labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-iodoethenyl)phenyl]nortropane as a potential radioligand for imaging the serotonin transporter by PET. Journal of Medicinal Chemistry. 49: 942-6. PMID 16451060 DOI: 10.1021/Jm050799V |
0.515 |
|
2005 |
McConathy J, Owens MJ, Kilts CD, Malveaux EJ, Votaw JR, Nemeroff CB, Goodman MM. Synthesis and biological evaluation of trans-3-phenyl-1-indanamines as potential norepinephrine transporter imaging agents. Nuclear Medicine and Biology. 32: 593-605. PMID 16026706 DOI: 10.1016/j.nucmedbio.2005.04.012 |
0.693 |
|
2005 |
Voll RJ, McConathy J, Waldrep MS, Crowe RJ, Goodman MM. Semi-automated preparation of the dopamine transporter ligand [(18)F]FECNT for human PET imaging studies. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 63: 353-61. PMID 15985372 DOI: 10.1016/j.apradiso.2005.04.008 |
0.6 |
|
2005 |
Jarkas N, McConathy J, Voll RJ, Goodman MM. Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands. Journal of Medicinal Chemistry. 48: 4254-65. PMID 15974579 DOI: 10.1021/jm050079o |
0.504 |
|
2005 |
Jarkas N, McConathy J, Votaw JR, Voll RJ, Malveaux E, Camp VM, Williams L, Goodman RR, Kilts CD, Goodman MM. Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography. Nuclear Medicine and Biology. 32: 75-86. PMID 15691664 DOI: 10.1016/j.nucmedbio.2004.07.001 |
0.583 |
|
2004 |
McConathy J, Owens MJ, Kilts CD, Malveaux EJ, Camp VM, Votaw JR, Nemeroff CB, Goodman MM. Synthesis and biological evaluation of [11C]talopram and [11C]talsupram: candidate PET ligands for the norepinephrine transporter. Nuclear Medicine and Biology. 31: 705-18. PMID 15246361 DOI: 10.1016/j.nucmedbio.2003.05.001 |
0.71 |
|
2004 |
Plisson C, McConathy J, Martarello L, Malveaux EJ, Camp VM, Williams L, Votaw JR, Goodman MM. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter. Journal of Medicinal Chemistry. 47: 1122-35. PMID 14971892 DOI: 10.1021/jm030384e |
0.527 |
|
2003 |
McConathy J, Owens MJ. Stereochemistry in Drug Action. Primary Care Companion to the Journal of Clinical Psychiatry. 5: 70-73. PMID 15156233 DOI: 10.4088/Pcc.V05N0202 |
0.485 |
|
2003 |
McConathy J, Martarello L, Malveaux EJ, Camp VM, Simpson NE, Simpson CP, Bowers GD, Zhang Z, Olson JJ, Goodman MM. Synthesis and evaluation of 2-amino-4-[(18)F]fluoro-2-methylbutanoic acid (FAMB): relationship of amino acid transport to tumor imaging properties of branched fluorinated amino acids. Nuclear Medicine and Biology. 30: 477-90. PMID 12831985 DOI: 10.1016/S0969-8051(03)00025-8 |
0.588 |
|
2003 |
McConathy J, Voll RJ, Yu W, Crowe RJ, Goodman MM. Improved synthesis of anti-[18F]FACBC: improved preparation of labeling precursor and automated radiosynthesis. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 58: 657-66. PMID 12798374 DOI: 10.1016/S0969-8043(03)00029-0 |
0.58 |
|
2003 |
Goodman MM, Chen P, Plisson C, Martarello L, Galt J, Votaw JR, Kilts CD, Malveaux G, Camp VM, Shi B, Ely TD, Howell L, McConathy J, Nemeroff CB. Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography. Journal of Medicinal Chemistry. 46: 925-35. PMID 12620070 DOI: 10.1021/Jm0100180 |
0.554 |
|
2002 |
Martarello L, McConathy J, Camp VM, Malveaux EJ, Simpson NE, Simpson CP, Olson JJ, Bowers GD, Goodman MM. Synthesis of syn- and anti-1-amino-3-[18F]fluoromethyl-cyclobutane-1-carboxylic acid (FMACBC), potential PET ligands for tumor detection. Journal of Medicinal Chemistry. 45: 2250-9. PMID 12014963 DOI: 10.1021/jm010242p |
0.588 |
|
2002 |
McConathy J, Martarello L, Malveaux EJ, Camp VM, Simpson NE, Simpson CP, Bowers GD, Olson JJ, Goodman MM. Radiolabeled amino acids for tumor imaging with PET: radiosynthesis and biological evaluation of 2-amino-3-[18F]fluoro-2-methylpropanoic acid and 3-[18F]fluoro-2-methyl-2-(methylamino)propanoic acid. Journal of Medicinal Chemistry. 45: 2240-9. PMID 12014962 DOI: 10.1021/jm010241x |
0.603 |
|
2001 |
McConathy J, Kilts CD, Goodman MM. Radioligands for PET and SPECT Imaging of the central noradrenergic system. Cns Spectrums. 6: 704-9. PMID 15520617 DOI: 10.1017/S1092852900001401 |
0.613 |
|
2001 |
Jarkas N, Mcconathy J, Ely T, Kilts CD, Votaw J, Goodman MM. Synthesis and radiolabeling of new derivatives of adam, potential candidates as sert imaging agents for pet Journal of Labelled Compounds and Radiopharmaceuticals. 44: S204-S206. DOI: 10.1002/Jlcr.2580440171 |
0.587 |
|
2001 |
Martarello L, McConathy J, Camp M, Malveaux E, Olson J, Bowers G, Goodman MM. Synthesis and biological evaluation of syn and anti FMACBC, new amino acids for tumor imaging with PET Journal of Labelled Compounds and Radiopharmaceuticals. 44: S385-S387. DOI: 10.1002/JLCR.25804401136 |
0.596 |
|
2001 |
McConathy J, Martarello L, Goodman MM. Introduction of 18F at neopentyl positions via cyclic sulfamidates: Synthesis of 18F-labeled α, α-dialkyl amino acids as potential tumor imaging agents Journal of Labelled Compounds and Radiopharmaceuticals. 44: S376-S378. DOI: 10.1002/JLCR.25804401133 |
0.561 |
|
Show low-probability matches. |